GenIP (AIM:TEK) has agreed a 12-month framework with a leading Hong Kong research university, renewable for a further 12 months, that enables portfolio-level evaluations of up to ten technologies per order and is valued at about $20,000 per year.
The company also won a first-time engagement with a London modern university covering ten reports, secured its first Canadian client (a leading research university) and an engagement with a major North American public research university that typically place monthly orders, and deployed its new Invention Validator in South Africa for a single-technology evaluation valued at about $14,500 with a stated 60% margin floor; GenIP is a technology consultancy that combines generative-AI and expert analysis to help research organisations and corporates commercialise innovations.
"Securing a framework agreement with the #1 ranked university for patent influence in China is a major validation of our new AI-driven products," Melissa Cruz, CEO.
GenIP will announce its FY2025 results within the next two weeks and will include an outlook in that release.
